Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Hansa Biopharma

29.12 SEK

-2.61 %

Less than 1K followers

HNSA

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hansa Biopharma

2019202020212022202320242025
Revenue3.46.133.9154.5134.1171.3222.3
growth-%81.3 %455.6 %356.1 %-13.2 %27.8 %29.7 %
EBITDA-359.7-422.8-547.0-587.1-788.5-637.4-520.7
EBIT-359.7-422.8-547.0-587.1-788.5-637.4-520.7
Profit before taxes-359.6-420.9-548.1-608.4-830.8-803.7-527.0
Net income-360.0-420.9-548.3-609.6-831.7-806.7-529.3
EPS-8.99-10.16-12.33-13.57-15.83-12.84-6.52
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-10,691.7 %-6,933.5 %-1,614.5 %-379.9 %-588.0 %-372.0 %-234.3 %
EBIT-%-10,691.7 %-6,933.5 %-1,614.5 %-379.9 %-588.0 %-372.0 %-234.3 %
ROE-64.0 %-33.9 %-72.4 %-100.6 %495.4 %136.9 %629.1 %
ROI-54.2 %-29.3 %-54.1 %-36.1 %-81.7 %-100.8 %-45.4 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.